These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 33278517)

  • 1. The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.
    Choudhary S; Sharma K; Silakari O
    Microb Pathog; 2021 Jan; 150():104673. PubMed ID: 33278517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection.
    Rasmi Y; Hatamkhani S; Naderi R; Shokati A; Nayeb Zadeh V; Hosseinzadeh F; Farnamian Y; Jalali L
    Acta Histochem; 2022 Jul; 124(5):151908. PubMed ID: 35662001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.
    Talukdar J; Bhadra B; Dattaroy T; Nagle V; Dasgupta S
    Biomed Pharmacother; 2020 Dec; 132():110886. PubMed ID: 33113418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
    J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune dysregulation and system pathology in COVID-19.
    Jamal M; Bangash HI; Habiba M; Lei Y; Xie T; Sun J; Wei Z; Hong Z; Shao L; Zhang Q
    Virulence; 2021 Dec; 12(1):918-936. PubMed ID: 33757410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.
    Zhang H; Shao B; Dang Q; Chen Z; Zhou Q; Luo H; Yuan W; Sun Z
    Front Immunol; 2021; 12():674074. PubMed ID: 34858386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions.
    Asrani P; Hassan MI
    Mol Cell Biochem; 2021 Feb; 476(2):675-687. PubMed ID: 33064288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
    Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Profiling of COVID-19 in Correlation with SARS and MERS.
    Khalil BA; Shakartalla SB; Goel S; Madkhana B; Halwani R; Maghazachi AA; AlSafar H; Al-Omari B; Al Bataineh MT
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
    Abdelmoaty MM; Yeapuri P; Machhi J; Olson KE; Shahjin F; Kumar V; Zhou Y; Liang J; Pandey K; Acharya A; Byrareddy SN; Mosley RL; Gendelman HE
    Front Immunol; 2021; 12():741502. PubMed ID: 34671355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.
    Cheon SY; Koo BN
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.